CASE STUDY

Creating Site-less
Clinical Trials

September 2021 – July 2022

The Business Challenge

Confirming someone’s identity and protecting sensitive data is critical in the medical industry. For this reason, we partnered with the Montreal Heart Institute (MHI) to solve some of the issues they are facing in today’s digital landscape.
Montreal Heart Institute

Creating Site-less Clinical Trials

Since September 2021, Kelvin Zero has been actively working with the Montreal Heart Institute (MHI) to integrate our techology into their hybrid and digital research programs. The result will be a fully connected identity and data encryption platform bringing new digital features to their research program. Among these features will be the digital onboarding of patients, consent management across decentralized networks, and site-less clinical trials.

Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat.

Delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat. Oni voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic 

Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat.

FACS: Clinical Trials

Our work with the MHI is connected to a $21.7M research program funded in part by the “Fonds d’accélération des collaborations en santé” (FACS) program of the Québec government. The objective of this project is to accelerate and facilitate research around cardiovascular, inflammatory, cancer, infectious, dementia, and cognitive diseases.

Fonds d'accélération des
collaborations en santé (FACS)

Project Highlights

Validating a patient’s identity digitally is critical to conducting successful digital and hybrid research programs. This is why we are deploying a unique identity encryption module at the MHI which will assign unique identifiers to their patients and use digital signatures to manage traceable patient access controls.

Capturing, tracing, and revoking consent is another major part of clinical trials. Consent can also be especially difficult to execute in a digital environment. To solve this issue, we are using SoLID to track and manage patient consent by linking patient identifiers to traceable digital transactions posted on a blockchain network.

Enabling remote and hybrid clinical trials is essential in today’s digital environment. To adapt to this reality, we are helping the MHI deploy an identity platform and consent system fit for secure patient management within totally remote and site-less clinical trial environments.

Put Multi-Pass in the hands of your customers
and workforce and take the first step
towards building your zero-trust architecture.

Embark on your zero-trust security journey. ​

Try Multi-Pass

CASE STUDIES

More Case Studies

Try Multi-Pass